Cefadroxil Capsule
Product Images NDC 57237-096

2 FDA label images from Rising Pharma Holdings, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cefadroxil (NDC 57237-096). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cefadroxil Str)

Chemical Structure (Cefadroxil Str)
Chemical structure of Cefadroxil, showing the molecular composition with a beta-lactam ring, a phenol group, and a monohydrate component. The diagram includes carbon, hydrogen, oxygen, nitrogen, and sulfur atoms arranged intricately.*
FDA Label Image

Package Label-principal Display Panel (500 mg (50 Capsule Bottle))

Package Label-principal Display Panel (500 mg (50 Capsule Bottle))
Label for Cefadroxil Capsules, USP 500 mg by Rising Pharma Holdings, Inc. The label indicates 50 capsules in the package, with the proprietary name Cefadroxil and a strength of 500 mg. It includes storage instructions, distributor information (Rising Health, LLC, Saddle Brook, NJ), and a barcode. The capsules are prescription-only and made in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.